MENU
KROS
AS OF
Nov 14, 01:38 PM (EDT)
Price
$17.48
Change
+$0.18 (+1.04%)
Capitalization
527.52M
110 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
KROS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Keros Therapeutics (KROS) Ownership - Who owns Keros Therapeutics?

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
527.52M
P/E Ratio
11.10
Total Cash
690.22M
Projected Growth
N/A
Total Debt
17.95M
Revenue
232.84M
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash/Share
22.66
Total Debt/Equity
N/A
Revenue/Share
6.02 USD as % of share price

Fundamentals

KROS
Capitalization
528M
P/E Ratio
11.10
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash
690M
Total Cash/Share
22.66
Total Debt
18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.02%
Revenue
233M
ROE
N/A
Book Value
707M
P/B Ratio
0.75
Cash Flow
N/A
Earnings
0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
21.11
Current Revenue Per Employee
122756.76
Dividends Per Share - Security
N/A
EBITDA
25.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
3.10
Shares Held By Institutions
638M
Shares Outstanding - Current
30.5M
Total Liabilities
50.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
9.286
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Choppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60minChoppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60min
Annualized Return+87%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
KROS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KROS showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for KROS
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com